ArticleDigestive diseases and sciences2023

Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae.

Laura Maas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.